Novavax | NVAX - Action





Action Changement Date
Adma Biologics USD 222.1M 15.63M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
Geron USD 133.29M 16.65M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
MannKind USD 49.17M 13.85M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Novartis USD 6.42B 114M 2025-09
Novavax USD 11.46M 87K 2026-03
Pfizer USD 10.67B 13M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
TG Therapeutics USD 129.03M 3.44M 2026-03